No, read carefully. I would have someone with exp
Post# of 148112
(Total Views: 371)
Posted On: 10/20/2021 11:12:39 AM
No, read carefully.
I would have someone with experience in trials (one I can indeed trust 100%) down there from the start of the enrollment until we hit at least 40%.
Like someone we had hired for CD12 who is checking onsite whats going on. Asking the doctors in the trial sites what's going on, where are problems, maybe misunderstandings what can be improved, support, etc.
Why should we still trust if we can check by ourselves?
We got burned heavily in the last years by too much trust (AMAREX, Pestell, Mahboob, ...)
Can we really afford "trust" in any institution (even Albert Einstein)? I do not think so.
I would have someone with experience in trials (one I can indeed trust 100%) down there from the start of the enrollment until we hit at least 40%.
Like someone we had hired for CD12 who is checking onsite whats going on. Asking the doctors in the trial sites what's going on, where are problems, maybe misunderstandings what can be improved, support, etc.
Why should we still trust if we can check by ourselves?
We got burned heavily in the last years by too much trust (AMAREX, Pestell, Mahboob, ...)
Can we really afford "trust" in any institution (even Albert Einstein)? I do not think so.
(5)
(1)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼